...
首页> 外文期刊>Retina >STUDY OF INHIBITORY EFFECTS OF AN ANTIANGIOGENIC SOMATOSTATIN-CAMPTOTHECIN CONJUGATE ON LASER-INDUCED CHOROIDAL NEOVASCULARIZATION IN RATS.
【24h】

STUDY OF INHIBITORY EFFECTS OF AN ANTIANGIOGENIC SOMATOSTATIN-CAMPTOTHECIN CONJUGATE ON LASER-INDUCED CHOROIDAL NEOVASCULARIZATION IN RATS.

机译:抗血管生成生长抑素-喜树碱共轭物对激光诱导的大鼠脉络膜神经新生的抑制作用研究。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE:: To evaluate the ocular toxicity and efficacy of intravitreal camptothecin-somatostatin conjugate (JF-10-81), a somatostatin type 2 receptor-directed, antiangiogenic compound. METHODS:: Part 1: New Zealand albino rabbits (except for controls) were injected intravitreally with conjugate at various concentrations. Preoperative and postoperative ocular examinations and electroretinography were performed until animals were killed for histology. Part 2: Long-Evans pigmented rats had choroidal neovascularization (CNV) induced by argon laser. One eye per animal was injected with concentration 10M (safe dose), whereas the other eyes were controls and received 30 muL of sterile water at different time intervals after laser application. Fluorescein angiography was performed at various time points to evaluate the lesions and confirm presence of CNV. Animals were euthanized. The eyes were immediately enucleated and prepared for histologic examination. RESULTS:: Part 1: No clinical changes were seen in groups receiving 10M, 10M, 10M, and 10 M of conjugate. Electroretinography showed decreasing b-wave amplitude in groups receiving 10 M and 10 M; cataracts also developed in these eyes. Part 2: Fluorescein angiography revealed that intravitreal injection of somatostatin conjugate JF-10-81 favorably affected the development of CNV when the treatment was performed at least 1 week after the laser application. These results were statistically significant. Histologic analysis results of eyes treated 2 weeks after laser application also showed significant benefit. CONCLUSIONS:: Part 1: Camptothecin-somatostatin conjugate injected intravitreally appeared safe at concentrations of 10M or less. Part 2: Conjugate JF-10-81 at a concentration of 10M administered intravitreally 1 to 3 weeks after laser demonstrated statistically significant efficacy in the treatment of choroidal neovascularization.
机译:目的:评价玻璃体内喜树碱-生长抑素偶联物(JF-10-81)(一种生长抑素2型受体导向的抗血管生成化合物)的眼毒性和疗效。方法:第1部分:向新西兰白化兔(对照除外)玻璃体内注射不同浓度的结合物。进行术前和术后眼科检查和视网膜电图检查,直到动物被处死为止。第2部分:患有长Evans色素的大鼠通过氩激光诱发脉络膜新生血管(CNV)。每只动物的一只眼睛注射浓度为10M(安全剂量)的激光,而另一只眼睛为对照,并在激光施加后的不同时间间隔接受30μL无菌水。在各个时间点进行荧光素血管造影,以评估病变并确认CNV的存在。使动物安乐死。立即摘除眼睛并准备进行组织学检查。结果:第1部分:接受10M,10M,10M和10 M结合物的组未见临床改变。视网膜电图显示在接收10 M和10 M的组中b波振幅减小;这些眼睛也出现白内障。第2部分:荧光素血管造影显示,在激光应用后至少1周进行治疗时,玻璃体腔内注射生长抑素偶联物JF-10-81会有利地影响CNV的发展。这些结果具有统计学意义。激光应用后两周治疗的眼睛的组织学分析结果也显示出明显的益处。结论:第1部分:玻璃体内注射的喜树碱-生长抑素结合物在10M或更低的浓度下似乎是安全的。第2部分:激光后1至3周玻璃体内给药的10M浓度的缀合物JF-10-81在治疗脉络膜新生血管方面显示出统计学显着的疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号